Anders Holmen Møller

Anders Holmen Møller is currently the Head of Market Access at AstraZeneca in Denmark, where they focus on optimizing the value demonstration of innovative treatments. Previously, they held positions as Head of Market Access Oncology at Novartis Danmark and as Global HEOR Manager at LEO Pharma, among others. Anders has a solid academic background, earning a Cand.Scient.Med in Medical Market Access and a BSc in Medicine with Industrial Specialization from Aalborg University. Their work emphasizes the importance of health economics and outcomes research to ensure patient access to effective treatments.